How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,587 results for

Cerebrovascular Accident Risk in Women

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association (Full text)

adult lives in increasing numbers, this development has resulted in an epidemiological shift and a generation of patients who are at risk of developing chronic multisystem disease in adulthood. Noncardiac complications significantly contribute to the morbidity and mortality of adults with CHD. Reduced survival has been documented in patients with CHD with renal dysfunction, restrictive lung disease, anemia, and cirrhosis. Furthermore, as this population ages, atherosclerotic cardiovascular disease (...) and its risk factors are becoming increasingly prevalent. Disorders of psychosocial and cognitive development are key factors affecting the quality of life of these individuals. It is incumbent on physicians who care for patients with CHD to be mindful of the effects that disease of organs other than the heart may have on the well-being of adults with CHD. Further research is needed to understand how these noncardiac complications may affect the long-term outcome in these patients and what modifiable

2017 American Heart Association PubMed

122. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

in adults ACC/AHA 2013 Cardiovascular diseases during pregnancy ESC 2011 Effectiveness-based guidelines for the prevention of cardiovascular disease in women AHA/ACC 2011 Secondary prevention and risk-reduction therapy for patients with coronary and other atherosclerotic vascular disease AHA/ACC 2011 Assessment of cardiovascular risk in asymptomatic adults ACC/AHA 2010 Thoracic aortic disease ACC/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM 2010 Diagnosis, evaluation, and treatment of high blood pressure (...) prevalence of hypertension and its associated increased risk of CHD, stroke, and end-stage renal disease (ESRD), the population-attributable risk of these outcomes associated with hypertension is high. In the population-based ARIC (Atherosclerosis Risk in Communities) study, 25% of the cardiovascular events (CHD, coronary revascularization, stroke, or HF) were attributable to hypertension. In the Northern Manhattan study, the percentage of events attributable to hypertension was higher in women (32

2017 American Heart Association

123. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association (Full text)

of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart Disease and Stroke Statistics—2017 Update A Report From the American Heart Association Key Words: AHA Scientific Statements ? cardiovascular diseases ? epidemiology ? risk factors ? statistics ? stroke © 2017 American Heart Association, Inc. Each chapter listed in the Table of Contents (see next page) is a hyperlink to that chapter. The reader clicks the chapter name to access that chapter. Downloaded from http (...) Behaviors 3. Smoking/Tobacco Use . . . . . . . . . . . . . . e183 4. Physical Inactivity . . . . . . . . . . . . . . . . e196 5. Nutrition . . . . . . . . . . . . . . . . . . . . . e214 6. Overweight and Obesity . . . . . . . . . . . . . e240 Health Factors and Other Risk Factors 7. Family History and Genetics . . . . . . . . . . . e263 8. High Blood Cholesterol and Other Lipids . . . . . e270 9. High Blood Pressure . . . . . . . . . . . . . . . e280 10. Diabetes Mellitus

2017 American Heart Association PubMed

124. Evidence for Therapeutic Patient Education Interventions to Promote Cardiovascular Patient Self-Management: A Scientific Statement for Healthcare Professionals From the American Heart Association

(cerebrovas- cular accident) populations, (2) intervention studies limited to pharmacological management, (3) interventions that targeted only the provider or health professional, (4) organizational or systems interventions to improve delivery of care, (5) life- style modification or coronary artery disease (CAD) risk fac- tor modification in lieu of cardiac rehabilitation after an acute cardiac event (ACS, CABG or PCI), or (6) cardiac rehabilita- tion implementation and evaluation. Non-English published (...) to overcome barriers BP monitoring Pharmacist-technician team visits Feedback to providers 6 mo Mean 4.25 visits Improved refill adherence (P< 0.001) Reduction in SBP (P< 0.001) BP control (P=0 01) Turner et al 41 (2012) Single-blind RCT N=280 I=136 C=144 Integrated chronic care model to reduce BP and CVD risk factors Education and counseling Peer coaching Print materials Computer program on CHD risk Printed materials Peer coaching, including bimonthly phone calls and 2 in-person sessions (15-30 min each

2017 American Heart Association

125. Benign Paroxysmal Positional Vertigo (BPPV)

Practice Guideline: Benign Paroxysmal Positional Vertigo (Update) .entryAuthor" data-author-container-selector=".NLM_contrib-group"> Show all authors , MD 1 1Department of Otolaryngology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA by this author for this author , , MD 2 2Department of Otolaryngology, School of Medicine and Public Health, University of Colorado, Aurora, Colorado, USA by this author for this author , , MD, MPH 3 3Department of Otolaryngology (...) Information Volume: 156 issue: 3_suppl, page(s): S1-S47 Article first published online: March 1, 2017; Issue published: March 1, 2017 , MD 1 , , MD 2 , , MD, MPH 3 , , MD 4 , , MD 5 , , MD 6 , , PT, DPT, NCS 7 , 8 , , MSN, FNP-BC 9 , , PhD 10 , , MD 11 , , MD, PhD 12 , , MD 13 , , MD, PhD 14 , , MD 15 , 16 1 Department of Otolaryngology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts, USA 2 Department of Otolaryngology, School of Medicine and Public Health, University

2017 American Academy of Otolaryngology - Head and Neck Surgery

126. Management of Osteoarthritis of the Hip

document. 5 RISK ASSESSMENT TOOLS Moderate strength evidence supports that the practitioner could use risk assessment tools to assist in predicting adverse events, assessing surgical risks and educating patients with symptomatic osteoarthritis of the hip undergoing total hip arthroplasty. Strength of Recommendation: Moderate Evidence Description: Evidence from two or more “Moderate” strength studies with consistent findings, or evidence from a single “High” quality study for recommending for or against (...) the intervention. OBESITY AS A RISK FACTOR a) Moderate strength evidence supports that obese patients with symptomatic osteoarthritis of the hip, when compared to non-obese patients, may achieve lower absolute outcome scores but a similar level of patient satisfaction and relative improvement in pain and function after total hip arthroplasty. Strength of Recommendation: Moderate Evidence Description: Evidence from two or more “Moderate” strength studies with consistent findings, or evidence from a single “High

2017 American Academy of Orthopaedic Surgeons

127. Management of Diabetes Mellitus in Primary Care

of clinical practice guidelines for the VA and DoD populations.[1] This clinical practice guideline (CPG) is intended to provide healthcare providers with a framework by which to evaluate, treat, and manage the individual needs and preferences of patients with diabetes mellitus (DM), thereby leading to improved clinical outcomes. The first VA/DoD CPG for the Management of Diabetes Mellitus, based upon earlier iterations in 1997 and 2000, was published in 2003.[2] It established a risk stratification (...) approach for setting individualized target goals based upon life expectancy, comorbid conditions, patient preferences, and absolute benefits and potential risks of therapy.[2] It also emphasized the risks of hypoglycemia. In 2010, the VA and DoD published a CPG for the Management of Diabetes Mellitus (2010 DM CPG), which was based on evidence reviewed through June 2009. Since the release of that guideline, a growing body of research has expanded the general knowledge and understanding of DM. Follow-up

2017 VA/DoD Clinical Practice Guidelines

128. Rehabilitation of Lower Limb Amputation

of arteriosclerosis and diabetes, patients with these conditions are at high risk for further complications to their amputated residual limb and/or amputation of the contralateral limb. In addition, they are at higher risk for other health problems such as cardiovascular disease, cerebrovascular accident, renal disease, peripheral neuropathy, etc. While this guideline focuses on rehabilitation of patients with LLA, preservation of the residual and contralateral limb, as well as the patients’ general health (...) training interventions, using both open and closed chain exercises and progressive resistance to improve gait, mobility, strength, cardiovascular fitness and activities of daily living performance in order to maximize function. Strong for Reviewed, New-replaced C. Pre-Prosthetic Phase 15. We suggest offering microprocessor knee units over non-microprocessor knee units for ambulation to reduce risk of falls and maximize patient satisfaction. There is insufficient evidence to recommend for or against any

2017 VA/DoD Clinical Practice Guidelines

129. Management of Opioid Therapy (OT) for Chronic Pain

Therapy B. Module B: Treatment with Opioid Therapy C. Module C: Tapering or Discontinuation of Opioid Therapy D. Module D: Patients Currently on Opioid Therapy V. Background A. Opioid Epidemic B. Paradigm Shift in Pain and Its Treatment C. Prioritizing Safe Opioid Prescribing Practices and Use D. Taxonomy E. Epidemiology and Impact F. Chronic Pain and Co-occurring Conditions G. Risk Factors for Adverse Outcomes of Opioid Therapy VI. About this Clinical Practice Guideline A. Scope of this Clinical (...) ui d el i n e f o r O p ioid T h e r a p y for Ch r on ic Pa in February 2017 Page 4 of 198 B. Risk Mitigation 46 51 70 71 75 75 75 80 81 81 88 99 100 105 105 110 116 116 120 122 C. Type, Dose, Duration, Follow-up, and Taper of Opioids D. Opioid Therapy for Acute Pain Appendix A: VA Signature Informed Consent Appendix B: Urine Drug Testing A. Benefits of Urine Drug Testing B. Types of Urine Drug Testing Appendix C: Diagnostic and Statistical Manual of Mental Disorders for Opioid Use Disorders

2017 VA/DoD Clinical Practice Guidelines

130. HTA of smoking cessation interventions

-term (six months or more) smoking cessation, and abstinence in late pregnancy in pregnant women. General adult population An updated systematic review identified 313 studies that met the inclusion criteria for the general adult population, half of which were published after January 2000. Sixty two percent of the studies had follow-up at 12 months or longer to estimate long-term abstinence. A quarter of the studies were considered at low risk of bias. Sixty five percent of the studies used (...) on the efficient and secure collection and sharing of health information, setting standards, evaluating information resources and publishing information about the delivery and performance of Ireland’s health and social care service. Health Technology Assessment (HTA) of smoking cessation interventions Health Information and Quality Authority 4 Foreword Given the higher risk of disease and death in smokers, the economic cost of smoking in Ireland is substantial. In 2013, the estimated cost to the healthcare

2017 Health Information and Quality Authority

131. Prevention, Diagnosis & Management of infective endocarditis

INTRODUCTION 24 2.0 EPIDEMIOLOGY 27 3.0 DIAGNOSIS 29 3.1 Clinical evaluation of suspected infective endocarditis 30 3.1.1 Pre-existing risk factors 30 3.1.2 Clinical manifestations 31 3.2 Investigations 34 3.2.1 Laboratory investigations 34 3.2.2 Microbiological diagnosis 34 3.2.3 Histopathological diagnosis 40 3.3 Imaging 43 3.3.1 Echocardiography 43 3.3.2 Other imaging modalities 50 3.4 Diagnostic criteria 53 3.4.1 The modified Duke criteria and its limitations 53 4.0 MANAGEMENT 57 4.1 Clinical (...) Transcatheter aortic valve implantation/ transcatheter aortic valve replacement 126 7.4 Infective endocarditis in cardiac implantable electronic devices 127 7.5 Infective endocarditis in pregnancy 129 8.0 ANTIMICROBIAL PROPHYLAXIS FOR INFECTIVE ENDOCARDITIS 130 8.1 Introduction 130 8.2 Cardiac conditions associated with the highest risk of infective endocarditis 130 8.3 Antimicr obial pr ophylaxis for specific pr ocedur es 131 8.3.1 Dental procedures 131 8.3.2 Non-dental procedures 132 8.4 Antimicrobial

2017 Ministry of Health, Malaysia

132. Guidance addressing all aspects of the care of people with schizophrenia and related disorders. Includes correct diagnosis, symptom relief and recovery of social function

expectancy of approximately 20% (Chwastiak and Tek, 2009; Saha 9 First published in Australian and New Zealand Journal of Psychiatry 2016, Vol. 50(5) 1-117. et al., 2007). Laursen (2011) found a reduction in life expectancy of 18.7 years for men and 16.3 years for women with schizophrenia. The leading causes of premature death among people with schizophrenia are cardiometabolic diseases, suicide and accidents (Laursen, 2011). The second Australian National Survey of Psychosis (Cooper et al., 2012 (...) , with aggregated SMR of 9.6 for men and 6.8 for women (Saha et al., 2007). Several risk factors have been suggested that are relatively specific to schizophrenia: the combination of young age and male sex, high level of education, the presence of insight, family history of suicide, substance use and the presence of depressive symptoms, hallucinations and delusions (Hor and Taylor, 2010). In an Australian study (Lawrence et al., 2000), the highest suicide risk was found in the first 7 days after discharge from

2016 Royal Australian and New Zealand College of Psychiatrists

133. CVD Prevention in Clinical Practice

B ARB angiotensin receptor blocker BEUC Bureau Européen des Unions de Consommateurs BMI body mass index (weight (kg)/height (m 2 )) BP blood pressure CAC coronary artery calcium CAD coronary artery disease CAPRIE Clopidogrel versus Aspirin in Patients at Risk for Ischaemic Events CARDS Collaborative Atorvastatin Diabetes Study CHANCE Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilisation (...) ,such as older people, the socially deprived and ethnic minorities, react toscreening. Despite limited evidence, these guidelines recommend a systematic approach to CVrisk assessment targeting populations likely to be at higher CV risk, such asthose with a family history of premature CVD. Thus systematic CV risk assessmentin men <40 years of age and women <50 years of age with no known CV riskfactors is not recommended. Additionally, screening of specific groups with jobsthat place other people at risk, e.g

2016 European Society of Cardiology

134. Wireless left ventricular pacing without coronary sinus

adverse events occurred, in one patient: a pocket haematoma, a femoral pseudo-aneurysm, and a cerebrovascular accident. A cerebrovascular accident occurred in a patient with prior atrial fibrillation in whom warfarin medication was interrupted. Effectiveness Implant times were 69 minutes (SD 14) for the ultrasonic transmitter, and 68 minutes (SD 27) for the receiver electrode. Auricchio et al 2014 25 This study reported on the outcomes of the NCT01294527 clinical trial. This trial intended to enrol (...) , weaken or damage the heart muscle over time. As the heart muscle deteriorates its ability to fill with blood and pump blood diminishes. 5 This can lead to a number of different symptoms that includes, shortness of breath, oedema, fatigue nausea, confusion and tachycardia. 12 In 2014, heart failure was the ninth most common cause of death in Australian women, with 1,975 women and 1,472 men dying of heart failure. 13 It is the third most common cardiovascular condition among Indigenous Australians

2016 COAG Health Council - Horizon Scanning Technology Briefs

135. Red cell transfusion in sickle cell disease Part II

, London. Available at https://www.nice.org.uk/guidance/cg68. Oduro, K.A. & Searle, J.F. (1972) Anaesthesia in sickle-cell states: a plea for simplicity. Br Med J, 4, 596-598. Ohene-Frempong, K. (2001) Indications for red cell transfusion in sickle cell disease. Semin Hematol, 38, 5-13. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood (...) /EVIDENCE_LEVELS_AND_GRADE S_OF_RECOMMENDATION/43_GRADE.html and the GRADE working group website http://www.gradeworkinggroup.org. Key recommendations Consideration of sickle cell patients for transfusion, particularly long-term regimens, should weigh up the potential benefits against potential risks (Grade 1C). Cerebrovascular disease: Regular transfusion to maintain HbS 20 g/l or to Hb 80 g/l) should be avoided due to the risk of hyperviscosity when sequestered red cells return to the circulation (Josephson, et al

2016 British Committee for Standards in Haematology

136. Treatment of HIV-1-positive adults with antiretroviral therapy (interim update)

120 8.6.5 Modification of CVD risk factors 121 8.6.6 References 124 8.7 Women 130 8.7.1 Introduction 130 8.7.2 When to start 130 8.7.3 What to start 130 8.7.4 HIV-positive women experiencing virological failure 133 8.7.5 References 134 8.8 Mental health 137 8.8.1 Recommendations 137 8.8.2 Rationale 137 8.8.3 References 138 8.9 Adolescents 139 BHIVA guidelines for the treatment of HIV-1-positive adults with ART 2015 (2016 interim update) August 2016 5 8.9.1 Recommendations for management of HIV (...) and women with an undetectable viral load and CD4 greater than 350 is the same as, or slightly better than, that for the general population [6]. Modelling has suggested that for HIV-positive men who have sex with men (MSM) living in a developed country with extensive access to HIV care and assuming a high rate of HIV diagnosis, the life expectancy is 75 years [7]. The authors concluded that the greatest risk of excess mortality is due to delays in HIV diagnosis. Decreasing late diagnosis

2017 British HIV Association

137. An Official ATS Statement: Impact of Mild Obstructive Sleep Apnea in Adults

of non–positive airway pressure (PAP) therapies on daytime sleepiness remains unclear. d A limited number of population-based and clinic-based studies provide con?icting data regarding the risk of motorvehicleaccidents as aconsequence of mild OSA. There are no studies on the impact of treatment of mild OSA on the risk for motor vehicle accidents. d Although the few studies that have evaluated the impact of mild OSA on quality of life have yielded con?icting results, most studies seem to show a small (...) ); if using a criterion of AHI greater than or equal to 5/h alone, the prevalence is much higher, ranging from 8 to 28% in adult men and 3 to 26% in adult women (2–4, 6, 8–12), respectively. Most of these population-based studies have estimated a two-to threefold greater risk for men than women. Over the years, there have been a number of attempts to standardize the de?nitions and diagnostic criteria for OSA to provide a uniform framework for comparing results of research investigations

2016 American Thoracic Society

138. Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science (Full text)

to be hospitalized because of cerebrovascular accident. Women in the Framingham Offspring Study 35 to 44 years of age with SLE were an astonishing 50 times more likely to have an AMI than women of the same age without SLE. Traditional (...) , perceptions, psychosocial characteristics, and behaviors. Sex- and gender-specific science addresses how experiences of the same disease, for example, ischemic heart disease (IHD), are similar and different with respect to biological sex and gender. For instance, women tend to have smaller coronary arteries than men, and women have less obstructive IHD than men. However, gender differences, which are influenced by ethnicity, culture, and socioeconomic environment, are intimately involved in risk factors

2016 American Heart Association PubMed

139. Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia

- vention Effectiveness for Alzheimer’s Disease CGI Clinical Global Impressions CGI-C Clinical Global Impression of Change CI Confidence interval CMAI Cohen-Mansfield Agitation Inventory CV A Cerebrovascular accident DLB Dementia with Lewy body DSM-IV Diagnostic and Statistical Manual of Mental Disorders, 4th Edition DSM-5 Diagnostic and Statistical Manual of Mental Disorders, 5th Edition EPS Extrapyramidal symptoms FAST Functional assessment staging FGA First-generation antipsychotic GRADE Grading (...) Symptoms of Dementia . . . . . . . . . . 3 Development of a Comprehensive Treatment Plan . . . . . . . . . . . . . . . . . . . . . . 3 Assessment of Benefits and Risks of Antipsychotic Treatment for the Patient. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3 Dosing, Duration, and Monitoring of Antipsychotic Treatment . . . . . . . . . . . . . 4 Use of Specific Antipsychotic Medications, Depending on Clinical Context

2016 American Psychiatric Association

140. Red Blood Cell Transfusion: 2016 Clinical Practice Guidelines from the AABB

, including 30-day mortality, myocardial infarction, cerebrovascular accident, rebleeding, pneumonia, or thromboembolism. For RBC storage duration, 13 RCTs included 5515 participants randomly allocated to receive fresher blood or standard-issue blood. These RCTs demonstrated that fresher blood did not improve clinical outcomes. Findings It is good practice to consider the hemoglobin level, the overall clinical context, patient preferences, and alternative therapies when making transfusion decisions (...) surgery, and those with preexisting cardiovascular disease (strong recommendation, moderate quality evidence). The restrictive transfusion threshold of 7 g/dL is likely comparable with 8 g/dL, but RCT evidence is not available for all patient categories. These recommendations do not apply to patients with acute coronary syndrome, severe thrombocytopenia (patients treated for hematological or oncological reasons who are at risk of bleeding), and chronic transfusion–dependent anemia (not recommended due

2016 AABB

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>